Altered expression of the developmentally regulated NFI gene family during phorbol ester-induced differentiation of human leukemic cells

Cell Growth and Differentiation

Volumn 7, Issue 4, 1996, Pages 501-510

  Kulkarni, Sucheta ^a   Gronostajski, Richard M ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; GENE CONTROL; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; HUMAN CELL; LEUKEMIA; PRIORITY JOURNAL;

BASE SEQUENCE; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; CLONING, MOLECULAR; CYCLOHEXIMIDE; DNA PROBES; DNA-BINDING PROTEINS; HUMANS; LEUKEMIA; MOLECULAR SEQUENCE DATA; NFI TRANSCRIPTION FACTORS; PROTEIN SYNTHESIS INHIBITORS; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; Y-BOX-BINDING PROTEIN 1;

EID: 0029808520     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Crossley, M., and Orkin, S. H. Regulation of the β-globin locus. Curr. Opin. Genet. Dev., 3: 232-237, 1993.
2. Philipson, S., Pruzina, S., and Grosveld, F. The minimal requirements for activity in transgenic mice of hypersensitive site 3 of the β globin locus control region. EMBO J., 72: 1077-1085, 1993.
3. Nagata, K., Guggenheimer, R., Enomoto, T., Lichy, J., and Hurwitz, J. Adenovirus DNA replication in vitro: identification of a host factor that stimulates synthesis of the preterminal protein-dCMP complex. Proc. Natl. Acad. Sci. USA, 79: 6438-6442, 1982.
4. Nagata, K., Guggenheimer, R. A., and Hurwitz, J. Specific binding of a cellular DNA replication protein to the origin of replication of adenovirus DNA. Proc. Natl. Acad. Sci. USA, 80: 6177-6181, 1983.
5. Santoro, C., Mermod, N., Andrews, P., and Tjian, R. A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs. Nature (Lond.), 334: 218-224, 1988
6. Kruse, U., Qian, F., and Sippel, A E. Identification of a fourth nuclear factor I gene in chicken by cDNA cloning: NFIX. Nucleic Acids Res., 19: 6641, 1991.
7. Apt, D., Liu, Y , and Bernard, H-U. Cloning and functional analysis of spliced isoforms of human nuclear factor I-X: interference with transcriptional activation by NFI/CTF in a cell-type specific manner. Nucleic Acids Res., 22: 3825-3833, 1994.
8. Rupp, R., Kruse, U., Multhaup, G., Gobel, U., Beyreuther, K., and Sippel, A. Chicken NFI/TGGCA proteins are encoded by at least three independent genes, NFI-A, NFI-B, and NFI-C with homologues in mammalian genomes. Nucleic Acids Res , 18: 2607-2616, 1990
9. Gounari, F., De Francesco, R., Schmitt, J., van der Vliet, P., Cortese, R., and Stunnenberg, H. Amino-terminal domain of NF1 binds to DNA as a dimer and activates adenovirus DNA replication. EMBO J., 9: 559-566, 1990.
10. Meisteremst, M., Rogge, L., Foeckler, R., Karaghiosoff, M., and Winnacker, E-L Structural and functional organization of a porcine gene coding for nuclear factor I. Biochemistry, 28: 8191-8200, 1989.
11. Gronostajski, R., Adhya, S., Nagata, K., Guggenheimer, R, and Hurwitz, J. Site-specific DNA binding of nuclear factor I. Analyses of cellular binding sites. Mol. Cell. Biol., 5: 964-971, 1985.
12. Gronostajski, R. Analysis of nuclear factor I binding to DNA using degenerate oligonucleotides. Nucleic Acids Res., 14: 9117-9132, 1986.
13. Gronostajski, R. Site-specific DNA binding of nuclear factor I. effect of the spacer region. Nucleic Acids Res., 15: 5545-5559, 1987.
14. Meisterernst, M., Gander, I., Rogge, L., and Winnacker, E. L A quantitative analysis of nuclear factor I/DNA interactions. Nucleic Acids Res , 16: 4419-4435, 1988
15. Kruse, U., and Sippel, A. E. Transcription factor nuclear factor I proteins form stable homo- and heterodimers. FEBS Lett., 348: 46-50, 1994.
16. Mermod, N., O'Neill, E., Kelly, T., and Tjian, R. The proline-rich transcriptional activator of CTF/NF-1 is distinct from the replication and DNA binding domain. Cell, 58: 741-753, 1989.
17. Inoue, T., Tamura, T., Furuichi, T., and Mikoshiba, K. Isolation of complementary DNAs encoding a cerebellum-enriched nuclear factor I family that activates transcription from the mouse myelin basic protein promoter. J. Biol. Chem., 265: 19065-19070, 1990.
18. Aoyama, A , Tamura, T , and Mikoshiba, K. Regulation of brain-specific transcription of the mouse myelin basic protein gene: function of the NF1-binding site in the distal promoter. Biochem. Biophys. Res. Commun., 167: 648-653, 1990.
19. Macleod, K., and Plumb, M. Derepression of mouse β-major-globin gene transcription during erythroid differentiation. Mol. Cell Biol., 11: 4324-4332, 1991.
20. π, the chicken embryonic α-globin gene. Mol. Cell. Biol., 13: 4632-4639, 1993
21. Cereghini, S., Raymondjean, M., Carranca, A. G., Herbomel, P., and Yaniv, M. Factors involved in control of tissue-specific expression of albumin gene. Cell, 50: 627-638, 1987.
22. Lichtsteiner, S., Wuarin, J., and Schibler, U. The interplay of DNA-binding proteins on the promoter of the mouse albumin gene. Cell, 51: 963-973, 1987.
23. Goyal, N., Knox, J., and Gronostajski, R. Analysis of multiple forms of nuclear factor I in human and murine cell lines. Mol. Cell. Biol., 70: 1041-1048, 1990.
24. Apt, D., Chong, T., Liu, Y., and Bernard, H-U. Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16. J. Virol., 67: 4455-4463, 1993.
25. Schuur, E. R., Kruse, U., Iacovoni, J. S., and Vogt, P. K. Nuclear factor I interferes with transformation induced by nuclear oncogenes. Cell Growth & Differ., 6: 219-227, 1995.
26. Rovera, G., Santoli, D., and Darnsky, C. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester Proc. Natl. Acad. Sci. USA, 76: 2779-2783, 1979.
27. Sakagami, H., Ozer, H., Minowada, J., Takeda, K., and Bloch, A. Differentiation-associated changes in human non-T, non-B leukemia cell lines after treatment with 12-O-tetradecanoylphorbol 13-acetate (TPA). Lenk. Res., 8: 187-195, 1984.
28. Rosson, D., and O'Brien, T. Constitutive c-myb expression in K562 cells inhibits induced erythroid differentiation but not tetracfecanoyl phorbol acetate-induced megakaryocytic differentiation. Mol. Cell. Biol , 15: 772-779, 1995.
29. Hass, R., Brach, M., Gunji, H., Kharbanda, S., and Kufe, D. Inhibition of EGR-1 and NF-KB gene expression by dexamethasone during phorbol ester-induced human monocytic differentiation. Biochem. Pharmacol., 44: 1569-1576, 1992.
30. Wang, C., Curtis, J. E., Minden, M. D., and McCulloch, E. A. Expression of a retinoic acid receptor gene in myeloid leukemia cells. Leukemia (Baltimore), 3: 264-269, 1989.
31. Leary, J., Ohlsson-Wilhelm, B., Giuliano, R., LaBella, S., Farley, B., and Rowley, P. Multipotent human hematopoietic cell line K562: lineage-specific constitutive and inducible antigens. Leuk. Res., 11: 807-815, 1987.
32. Ways, D., Qin, W., Garris, T., Chen, J., Hao, E , Cooper, D., Usala, S., Parker, P., and Cook, P. Effects of chronic phorbol ester treatment on protein kinase C activity, content, and gene expression in the human monoblastoid U937 cell. Cell Growth & Differ., 5: 161-169, 1994.
33. Collins, S. J. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood, 70: 1233-1244, 1987.
34. Lishner, M , Curtis, J. E., Minkin, S., and McCulloch, E. A. Interaction between retinoic acid and cytosine arabinoside affecting the blast cells of acute myeloblastic leukemia Leukemia (Baltimore), 3: 784-788, 1989.
35. McCulloch, E. A. Stem cell renewal and determination during clonal expansion in normal and leukaemic haemopoiesis. Cell Prolif., 26: 399-425, 1993.
36. Nebl, G., Mermod, N., and Cato, A C. B. Post-transcriptional down-regulation of expression of transcription factor NF1 by Ha-ras oncogene. J. Biol. Chem, 269: 7371-7378, 1994.
37. Kruse, U., and Sippel, A. The genes for transcription factor nuclear factor I give rise to corresponding splice variants between vertebrate species. J. Mol. Biol., 238: 860-865, 1994.
38. Knox, J. J., Rebstein, P. J., Manoukian, A., and Gronostajski, R. M. In vivo stimulation of a chimeric promoter by binding sites for nuclear factor I. Mol Cell. Biol., 11: 2946-2951, 1991.
39. Gronostajski, R M., Knox, J., Berry, D., and Miyamoto, N. G. Stimulation of transcription in vitro by binding sites for nuclear factor I. Nucleic Acids Res., 16: 2087-2098, 1988.
40. Mink, S., Hartig, E., Jennewein, P., Doppler, W., and Cato, A. C. B. A mammary cell-specific enhancer in MMTV DNA is composed of multiple regulatory elements including binding sites for CTF/NFI and a novel transcription factor, mammary cell-activating factor. Mol. Cell. Biol., 12: 4906-4918, 1992.
41. Abraham, L. J., Bradshaw, A. D., Shiels, B. R., Northemann, W., Hudson, G., and Fey, G. H. Hepatic transcription of the acute-phase α1-inhibitor III gene is controlled by a novel combination of cis-acting regulatory elements. Mol. Cell. Biol., 10: 3483-3491, 1990.
42. Graves, R. A., Tontonoz, P., Ross, S. R , and Spiegelman, B. M. Identification of a potent adipocyte-specific enhancer: involvement of an NF-1-like factor. Genes & Dev., 5: 428-437, 1991.
43. Wendler, W., Altmann, H., and Ludwig-Winnacker, E. Transcriptional activation of NFI/CTF1 depends on a sequence motif strongly related to the carboxyterminal domain of RNA polymerase II. Nucleic Acids Res., 22: 2601-2603, 1994
44. Kim, T. K., and Roeder, R. G. Transcriptional activation in yeast by the proline-rich activation domain of human CTF1. J. Biol. Chem., 268: 20866-20869, 1993
45. Garcia-Fernandez, J , and Holland, P. W. H. Archetypal organization of the amphioxus Hox gene cluster. Nature (Lond.), 370: 563-566, 1994.
46. Tohda, S., Yang, G., Ashman, L., McCulloch, E., and Minden, M. Relationship between c-kit expression and proliferation in acute myeloblastic leukemia cell lines. J. Cell Physiol., 754: 410-418, 1993.
47. Lozzio, B., Lozzio, C., Bamberger, E., and Feliu, A. A multipotential leukemia cell line (K-562) of human origin (41106). Proc. Soc. Exp. Biol. Med , 166: 546-550, 1981.
48. Collins, S., Ruscetti, F., Gallagher, R., and Gallo, R Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl. Acad. Sci. USA, 75: 2458-2462, 1978.
49. Sundstrom, C., and Niisson, K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer, 17: 564-577, 1976.
50. Novak, A., Goyal, N., and Gronostajski, R. M. Four conserved cysteine residues are required for the DNA binding activity of nuclear factor I. J. Biol. Chem., 267: 12986-12990, 1992.
51. Bandyopadhyay, S., and Gronostajski, R. Identification of a conserved oxidation-sensitive cysteine residue in the NFI family of DNA-binding proteins. J. Biol. Chem., 269: 29949-29955, 1994.
52. Paonessa, G., Gounari, F., Frank, R., and Cortese, R. Purification of a NFI-like DNA binding protein from rat liver and cloning of the corresponding cDNA. EMBO J., 7: 3115-3123, 1988.
53. Gil, G., Smith, J. R., Goldstein, J. L., Slaughter, C. A., Orth, K., Brown, M. S., and Osborne, T F Multiple genes encode nuclear factor 1-like proteins that bind to the promoter for 3-hydroxy-3-methyiglutaryl-coenzyme A reductase Proc. Natl. Acad. Sci. USA, 85: 8963-8967, 1988.
54. Maxam, A., and Gilbert, W. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol., 65: 499-560, 1980.
55. Kingston, R. E. Preparation of RNA from eukaryotic and prokaryotic cells., Curr. Protocols Mol. Biol., 10(Suppl.): 4.2 1-4.2.8, 1992.